Brain tumors in children

Current Opinion in Pediatrics

Volumn 8, Issue 6, 1996, Pages 549-557

  Packer, Roger J ^a  

^a CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASTROCYTOMA; BRAIN STEM TUMOR; BRAIN TUMOR; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CHILDHOOD CANCER; DISEASE CLASSIFICATION; EPENDYMA; HUMAN; MEDULLOBLASTOMA; PRIORITY JOURNAL; RADIODIAGNOSIS; REVIEW; TREATMENT PLANNING;

EID: 0030457875     PISSN: 10408703     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008480-199612000-00003     Document Type: Review

References (41)

1. Burger PC: Revising the World Health Organization (WHO) blue book: 'Histological Typing of Tumors of the Central Nervous System.' J Neurooncol 1995, 24:3-7. This is a brief review of changes in the international classification system proposed by the World Health Organization. This system has become the readily accepted standard throughout the world and describes new categories of pediatric brain tumors.
2. Collins VP: Genetic alterations in gliomas. J Neurooncol 1995, 24:37-38.
3. Batra SK, McLendon RE, Koo JS, Castelino-Prabhu S, Fuchs HE, Krischer JP, Friedman HS, Bigner DD, Bigner SH: Prognostic implications of chromosome 17p deletions in human medulloblastomas. J Neurooncol 1995, 24:39-45.
4. Hoyt JW, Gown AM, Kim DK, Berger MS: Analysis of proliferative grade in glial neoplasms using antibodies to the Ki-67 defined antigen and PCNA in formalin fixed, deparaffinized tissues. J Neurooncol 1995, 24:163-169.
5. Chou PM, Reyes-Mugica M, Barquin N, Yasuda T, Tan X, Tomita T: Multidrug resistance gene expression in childhood medulloblastoma: correlation with clinical outcome and DNA ploidy in 29 patients. Pediatr Neurosurg 1995, 23:283-292.
6. Rollins NK, Lowry PA, Shapiro KN: Comparison of gadolinium-enhanced MR and thallium-201 single photon emission computed tomography in pediatric brain tumors. Pediatr Neurosurg 1995, 22:8-14.
7. Gilles FH, Sobel EL, Tavare CJ, Leviton A, Hedley-Whyte ET: Age-related changes in diagnoses, histological features, and survival in children with brain tumor: 1930-1979. The Childhood Brain Tumor Consortium. Neurosurgery 1995, 37:1056-1068.
8. Jones SM, Phillips PC, Molloy PT, Lange BJ, Needle MN, Bunin GR, Biegel JA: Neurologic and other disorders in relatives of pediatric patients with CNS tumors. Pediatr Neurol 1995, 13:111-116.
9. Preston-Martin S, Navidi W, Thomas D, Lee PJ, Bowman J, Pogoda J: Los Angeles study of residential magnetic fields and childhood brain tumors. Am J Epidemiol 1996, 143:105-119.
10. Whitton AC, Syndikus I, Tait DM, Bloom HJ: Radiotherapy and adjuvant chemotherapy for childhood medulloblastoma: the Royal Marsden Hospital experience. Strahlenther Onkol 1995, 171:615-621.
11. Albright AL, Wisoff JH, Zeltzer PM, Boyett JM, Rorke LB, Stanley P: Effects of medulloblastoma resections on outcome in children: a report from the Childrens Cancer Group. Neurosurgery 1996, 38:265-271. This is an initial report on the use of preradiation chemotherapy done with the eight-drug-in-1-day approach. It shows the benefit of aggressive resection in children with medulloblastoma. It also reviews the early data on the efficacy of preradiation chemotherapy and the effect of various other risk factors on outcome in patients with disease.
12. Bailey CC, Gnekow A, Wellek S, Jones M, Round C, Brown J, Phillips A, Neidhardt MK: Prospective randomised trial of chemotherapy given before radiotherapy in childhood medulloblastoma: International Society of Paediatric Oncology (SOP) and the (German) Society of Paediatric Oncology (GPO). SIOP II. Med Pediatr Oncol 1995, 25:166-178. This is a difficult-to-read but important study showing that survival rates in children with nondisseminated medulloblastoma were similar for children who received full-dose craniospinal radiation and those who received reduced-dose craniospinal radiation. This report also suggests that delaying radiation in children who do not have disseminated disease at time of diagnosis may result in poorer overall outcome.
13. Goldwein JW, Radcliffe JR, Johnson J, Moshang T, Packer RJ, Sutton LN, Rorke LB, D'Angio JD: Updated results of a pilot study of low dose craniospinal irradiation plus chemotherapy for children under five with cerebellar primitive neuroectodermal tumors (medulloblastoma). Int J Radiat Oncol Biol Phys 1996, 34:899-904.
14. Albright AL, Wisoff JH, Zeltzer P, Boyett J, Rorke LB, Stanley P, Geyer JR, Milstein JM: Prognostic factors in children with supratentorial (nonpineal) primitive neuroectodermal tumors. Pediatr Neurosurg 1995, 22:1-7.
15. Cohen BH, Zeltzer PM, Boyett JM, Geyer JR, Allen JC, Finlay JL, McGuire-Cullen P, Milstein MJ, Rorke LB, Stanley P, et al.: Prognostic factors and treatment results for supratentorial primitive neuroectodermal tumors in children using radiation and chemotherapy: a Childrens Cancer Group randomized trial. J Clin Oncol 1995, 13:1687-1696.
16. Jakacki RI, Zeltzer PM, Boyett JM, Albright AL, Allen JC, Geyer JR, Rorke LB, Stanley P, Stevens KR, Wisoff J, et al.: Survival and prognostic factors following radiation and/or chemotherapy for primitive neuroectodermal tumors of the pineal region in infants and children: a report of the Chlldrens Cancer Group. J Clin Oncol 1995, 13:1377-1383.
17. Packer RJ, Prados M, Phillips P, Nicholson HS, Boyett JM, Goldwein J, Rorke LB, Needle MN, Sutton L, Zimmerman RA, et al.: Treatment of children with newly diagnosed brain stem gllomas with intravenous recombinant β-interferon and hyperfractionated radiation therapy: a Childrens Cancer Group phase I/II study. Cancer 1996, 77:2150-2156. This report discusses the innovative use of interferon with radiotherapy for children with brainstem gliomas. Although such therapy was well tolerated, overall outcome remained quite poor.
18. Robertson PL, Muraszko KM, Brunberg JA, Axtell RA, Dauser RC, Turrisi AT: Pediatric midbrain tumors: a benign subgroup of brainstem gliomas. Pediatr Neurosurg 1995, 22:65-73.
19. Pollack IF, Shultz B, Mulvihill JJ: The management of brainstem gliomas in patients with neurofibromatosis 1. Neurology 1996, 46:1652-1660.
20. Campbell JW, Pollack IF, Martinez AJ, Shultz B: High-grade astrocytomas in children: radiologically complete resection is associated with an excellent long-term prognosis. Neurosurgery 1996, 38:258-264. This interesting report suggests that complete resection is associated with excellent long-term control in children with malignant cortical astrocytomas. This experience has not been replicated by any other group.
21. Janss AJ, Grundy R, Cnaan A, Savino PJ, Packer RJ, Zackai EH, Goldwein JW, Sutton LN, Radcliffe J, Molloy PT, et al: Optic pathway and hypothalamic/chiasmatic gliomas in children younger than age 5 years with a 6-year follow-up. Cancer 1995, 75:1051-1059. This is a review of extensive experience using either observation or chemotherapy for children with chiasmatic gliomas who are younger than 5 years of age at the time of diagnosis. It expands on previously published data.
22. Sutton LN, Molloy PT, Sernyak H, Goldwein J, Phillips PL, Rorke LB, Moshang T, Lange B, Packer RJ: Long-term outcome of hypothalamic/chiasmatic astrocytomas in children treated with conservative surgery. J Neurosurg 1995, 83:583-589.
23. Listemick R, Darling C, Greenwald M, Strauss L, Charrow J: Optic pathway tumors in children: the effect of neurofibromatosis type 1 on clinical manifestations and natural history. J Pediatr 1995, 127:718-722. This report shows the relatively benign natural history of the optic nerve in chiasmatic gliomas in children with neurofibromatosis.
24. Khajavi K, Comair YG, Prayson RA, Wyllie E, Palmer J, Estes ML, Hahn JF: Childhood ganglioglioma and medically intractable epilepsy. Pediatr Neurosurg 1995, 22:181-188.
25. Pollack IF, Claassen D, Al-Shboul Q, Janosky JE, Deutsch M: Low-grade gliomas of the cerebral hemispheres in children: an analysis of 71 cases. J Neurosurg 1995, 82:536-547.
26. Duffner PK, Kun LE, Burger PC, Horowitz ME, Cohen ME, Sanford RA, Krischer JP, Mulhern RK, James HE, Rekate HL, et al.: Postoperative chemotherapy and delayed radiation in infants and very young children with choroid plexus carcinomas. Pediatr Neurosurg 1995, 22:189-196.
27. Dupuis-Girod S, Hartmann O, Benhamou E, Doz F, Mechinaud F, Bouffet E, Coze C, Kalifa C: Will high dose chemotherapy followed by autologous bone marrow transplantation supplant cranio-spinal irradiation in young children treated for medulloblastoma? J Neurooncol 1996, 27:87-98. This very interesting report describes the use of higher-dose chemotherapy plus autologous bone marrow rescue in children who failed to respond to initial chemotherapy for malignant high-grade glioma. The authors show impressive rates of disease control in patients who had local recurrence after high-dose chemotherapy supplemented by local radiotherapy. In contrast, independent of the use of high-dose craniospinal radiation therapy, patients who had craniospinal disease at the time of progression all failed to respond to treatment.
28. Jayawickreme DP, Hayward RD, Harkness WF: Intracranial ependymomas in childhood: a report of 24 cases followed for 5 years. Childs Nerv Syst 1995, 11:409-413.
29. Pollack IF, Gerszten PC, Martinez AJ, Lo KH, Shultz B, Albright AL, Janosky J, Deutsch M: Intracranial ependymomas of childhood: long-term outcome and prognostic factors. Neurosurgery 1995, 37:655-666.
30. Carrie C, Mottolese C, Bouffet E, Negrier S, Bachelot TH, Lasset C, Helfre S, Guyotat J, Lapras CL, Brunat-Mentigny M: Non-metastatic childhood ependymomas. Radiother Oncol 1995, 36:101-106.
31. Rorke L, Packer RJ, Biegel J: Central nervous system atypical teratoid rhabdoid tumors of Infancy and childhood: definition of an entity. J Neurosurg 1996, 85:56-65. This important paper carefully describes 52 children with atypical teratoid rhabdoid tumors. It discusses the largest series in the literature and thoroughly reviews all aspects of this tumor and lack of response to therapy.
32. Molloy PT, Yachnis AT, Rorke LB, Dattilo JJ, Needle MN, Millar WS, Goldwein JW, Sutton LN, Phillips PC: Central nervous system medulloepithelioma: a series of eight cases including two arising in the pons. J Neurosurg 1996, 84:430-436.
33. Wilson JT, Wald SL, Aitken PA, Mastromateo J, Vieco PT: Primary diffuse chiasmatic germinomas: differentiation from optic chiasm gliomas. Pediatr Neurosurg 1995, 23:1-6.
34. Wara W, Bauman G, Gutin P, Circillo S, Larson D, McDermott M, Sneed P, Verhey L, Smith V, Petti P, et al.: Stereotactic radiosurgery in children. Stereotact Fund Neurosurg 1995, 64:118-125.
35. Kun LE, Gajjar A, Muhlbauer M, Heideman RL, Sanford R, Brenner M, Walter A, Langston J, Jenkins J, Facchini S: Stereotactic injection of herpes simplex thymidine kinase vector producer cells (PA317-G1Tk1SvNa.7) and Intravenous ganciclovir for the treatment of progressive or recurrent primary supratentorial pediatric malignant brain tumors. Hum Gene Ther 1995, 6:1331-1355.
36. Heideman RL, Douglass EC, Langston JA, Krischer JP, Burger PC, Kovnar EH, Kun LE, Friedman HS, Kadota R: A phase II study of every other day high-dose ifosfamide in pediatric brain tumors: a Pediatric Oncology Group study. J Neurooncol 1995, 25:77-84.
37. Abrahamsen TG, Lange BJ, Packer PJ, Venzon DJ, Allen JC, Craig CE, et al.: A phase I and II trial of dose-intensified cyclophosphamide and GMCSF in pediatric malignant brain tumors. J Pediatr Hematol Oncol 1995, 17:134-139.
38. Shuper A, Packer RJ, Vezina LG, Nicholson HS, LaFond D: 'Complicated migraine-like episodes' in children following cranial irradiation and chemotherapy. Neurology 45:1837-1840.
39. Pollack IF, Polinko P, Albright AL, Towbin R, Fitz C: Mutism and pseudobulbar symptoms after resection of posterior fossa tumors in children: Incidence and pathophysiology. Neurosurgery 1995, 37:885-893.
40. Kimmings E, Kleinlugtebeld AT, Casey A, Hayward RD: Medulloblastoma: factors influencing the educational potential of surviving children. Br J Neurosurg 1995, 9:611-617.
41. Carlson-Green B, Morris RD, Krawiecki N: Family and illness predictors of outcome in pediatric brain tumors. J Pediatr Psychol 1995, 20:769-784. This interesting and controversial paper suggests that family stresses are significant predictors of quality of life in children with medulloblastoma.